Literature DB >> 1469522

Increased serum IL-2R levels in coeliac disease are related to CD4 but not CD8 antigens.

A Blanco1, J A Garrote, E Arranz, M Alonso, C Clavo.   

Abstract

Forty-three coeliac children, ranging from 1 year and 3 months to 14 years and 9 months, were studied. Twenty-eight patients were in an active phase of the disease, and 15 were in remission. The criteria of coeliac disease (CD) activity were established according to the results of IgA anti-endomysial antibodies (IgA-AEm). Interleukin 2 receptor (IL-2R) and CD4 and CD8 antigens were measured in serum samples by an ELISA technique using two noncompetitive monoclonal antibodies. Antigliadin antibodies of IgG (IgG-AGA) and IgA (IgA-AGA) classes were also measured. The AEm-positive coeliac patient group showed values of 1,860 +/- 948 U/ml for IL-2R, 430 +/- 228 U/ml for CD8, and 36.8 +/- 25.1 U/ml for CD4. AEm-negative patients showed values of 980 +/- 436 U/ml, 350 +/- 243 U/ml, and 24.1 +/- 20 U/ml, respectively. IL-2R levels were the only ones significantly elevated (p < 0.005) in the active coeliac group. On the other hand, IgG-AGA and IgA-AGA were both clearly increased (p < 0.001). IL-2R levels in active coeliac patients correlated with CD4 levels (p < 0.05), but not with CD8, IgG-AGA, and IgA-AGA levels. We also found a surprising negative correlation between AEm antibodies of IgA2 class with both IL-2R (r = 0.471; p < 0.05) and CD8 (r = 0.616; p < 0.05). The results show that in CD there is a lymphocyte activation affecting mainly CD4+ cells and not correlated with serum AGA levels, suggesting an independence of both immunological phenomena and probably with different locations of origin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1469522     DOI: 10.1097/00005176-199211000-00008

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  4 in total

Review 1.  Cutting-edge issues in celiac disease and in gluten intolerance.

Authors:  N Bizzaro; R Tozzoli; D Villalta; M Fabris; E Tonutti
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

2.  Serum soluble interleukin-2 receptor, interleukin-6 and tumor necrosis factor alpha as markers of celiac disease activity.

Authors:  Akshay Kapoor; A K Patwari; Praveen Kumar; Anju Jain; Shashi Narayan
Journal:  Indian J Pediatr       Date:  2012-07-06       Impact factor: 1.967

3.  Serum parameters in the spectrum of coeliac disease: beyond standard antibody testing--a cohort study.

Authors:  Greetje J Tack; Roy L J van Wanrooij; B Mary E Von Blomberg; Hedayat Amini; Veerle M H Coupe; Petra Bonnet; Chris J J Mulder; Marco W J Schreurs
Journal:  BMC Gastroenterol       Date:  2012-11-12       Impact factor: 3.067

4.  The Predictive Value of Serum Cytokines for Distinguishing Celiac Disease from Non-Celiac Gluten Sensitivity and Healthy Subjects

Authors:  Fatemeh Masaebi; Mehdi Azizmohammad Looha; Mohammad Rostami-Nejad; Mohamad Amin Pourhoseingholi; Navid Mohseni; Gabriel Samasca; Iulia Lupan; Mostafa Rezaei-Tavirani; Mohammad Reza Zali
Journal:  Iran Biomed J       Date:  2020-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.